#cancervaccines
LightNews LightNews
uwcvi.bsky.social
Thank you, In Concert for Cancer, for bringing the community together in support of our cancer vaccine research. We are grateful for your partnership and commitment to advancing research toward a cancer-free future.

#InConcertforCancer #CancerVaccines #CancerResearch
October 2, 2026 at 3:15 PM
uwcvi.bsky.social
Dr. Nora Disis, CVI Director, is a lead author of a new review article published by @jama.com.

The review explores the science behind cancer vaccines and the field’s shifting focus toward preventive approaches.

Read more: www.uwcvi.org/post/dr-disi...

#CancerVaccines #CancerResearch
September 21, 2026 at 6:33 PM
uwcvi.bsky.social
September is Ovarian Cancer Awareness Month. The CVI is exploring how cancer vaccines can program the immune system to treat ovarian cancer, prevent recurrence, and prevent the disease altogether.

Read more: www.uwcvi.org/post/ovarian...

#OvarianCancer #CancerResearch #CancerVaccines
September 4, 2026 at 3:21 PM
earthinsider.bsky.social
Moderna and Merck Reveal New Cancer Vaccine Results That Could Change Oncology Forever

Full story 👇

Learn more: https://www.earthinsider.in/2026/08/moderna-merck-cancer-vaccines-clinical.html

#EarthInsider #EarthInsiderNews #EINews #Global #WorldNews #BreakingNews #GlobalAffairs #CancerVaccines
Moderna Merck Cancer Vaccines Unveil Clinical Trial Results
Moderna Merck cancer vaccines show new clinical trial results, transforming oncology and personalized medicine. Find out what happened.
www.earthinsider.in
August 21, 2026 at 3:13 AM
onclive.bsky.social
PTVG-HP DNA vaccine demonstrated an overall survival benefit vs placebo in patients with PSA-recurrent prostate cancer. 📊✨
Read more ➡️ www.onclive.com/view/ptvg-hp...
#ProstateCancer #GUonc #CancerVaccines #Immunotherapy #DNAvaccine #PrecisionOncology #Oncology
pTVG-HP DNA Vaccine Extends Overall Survival vs Placebo in PSA-Recurrent Prostate Cancer | OncLive
Long-term follow-up showed pTVG-HP nearly doubled median OS compared with placebo in biochemically recurrent prostate cancer.
www.onclive.com
August 20, 2026 at 9:07 PM
vaccinologist.bsky.social
🆕 #Moderna and #Merck report positive Phase 3 results for personalized #mRNA therapy intismeran autogene + #pembrolizumab in resected Stage IIB–IV #melanoma. A major proof-of-concept for individualized #cancervaccines and mRNA #immunotherapy. www.linkedin.com/posts/drmelv...
August 19, 2026 at 8:33 PM
vaccinesconference.bsky.social
🔬 Therapeutic & Cancer Vaccines: Advancing the Future

Explore next-generation vaccine platforms, tumor-targeted immune responses & translational cancer research at #VACCINES2027.

📍 Milan, Italy
📅 April 19–20, 2027
🔗 vaccinesresearch2027.pagesconferences.org

#CancerVaccines #Vaccines
August 11, 2026 at 10:49 AM
sigtrans-sttt.bsky.social
Combinatorial in situ #CancerVaccines integrate local immune activation with complementary therapies to improve antigen presentation, overcome tumor #Immunosuppression, and generate durable antitumor immune responses.

#STTT #OpenAccess: doi.org/10.1038/s413...
Combinatorial in situ cancer vaccines: unlocking broad and enhanced antitumor responses
July 30, 2026 at 6:00 AM
uwcvi.bsky.social
Dr. Nora Disis, CVI Director, was featured on OncNow, a podcast by the @emjreviews.com. She talked about the science behind therapeutic and preventive cancer vaccines. Read more here: www.uwcvi.org/post/that-is...

#CancerResearch #WomenInSTEM #CancerVaccines
July 27, 2026 at 3:36 PM
thebabaklab.bsky.social
Can pancreatic cancer be intercepted before it develops?
Most pancreatic cancers begin with KRAS mutations, often years before an invasive tumor appears.

Link in the comments 👇

#PancreaticCancer #KRAS #CancerVaccines #CancerPrevention #Immunotherapy #ClinicalTrials
July 27, 2026 at 3:30 PM
reckoning-ball.bsky.social
When the same mRNA vaccine technology that created the Covid vaccines is used to make #CancerVaccines and you have a population that can cure their cancers with a public healthcare system, who's choosing the juice cleanse influencer supplements. Watch for #wellnesswhiplash
www.cbc.ca/news/health/...
COVID proved mRNA vaccine technology was safe and effective, review says. Is a cancer vaccine next? | CBC News
The mRNA vaccines approved to treat COVID-19 are safe and effective and show promise in treating other diseases including cancer, according to a new review published in The Lancet Tuesday.
www.cbc.ca
July 1, 2026 at 9:59 AM
melanomafocus.bsky.social
Read more about cancer vaccines and what these findings could mean for the future HERE: bit.ly/Personalised...

#Melanoma #MelanomaResearch #CancerResearch #Immunotherapy #CancerVaccines #MelanomaAwareness #ResearchNews
(5/5)
Personalised Cancer Vaccine Shows Promising Long-term Results in Advanced Melanoma
ASCO 2026: Five-year results from an early cancer vaccine study showed promising outcomes for patients with high-risk melanoma.
bit.ly
June 11, 2026 at 12:00 PM
oicr.on.ca
Watch our latest "Ask a Cancer Researcher" video with Dr. Raymond Kim to find out how vaccines are being developed to prevent cancers in individuals living with Lynch syndrome, who are at a much greater risk of developing cancer.

#OICR #cancerresearch #immunotherapy #cancervaccines #Lynchsyndrome
June 9, 2026 at 7:46 PM
imtadvances.bsky.social
Attending #CIMT2026?

Immunotherapy Advances is welcoming submissions to its Cancer Vaccines – Global Advances collection (deadline extended to July 2026).

Hear more from Guest Editor Prof Lennard Lee, speaking at CIMT today at 14:00.

#CancerVaccines #Immunotherapy
Promotional graphic for a special collection on global advances in cancer vaccines, led by prominent experts. Hosted by the British Society for Immunology.
May 12, 2026 at 10:17 AM
uwcvi.bsky.social
Dr. Nora Disis, CVI Director, joined the Presidential Select Symposium at the 2026 AACR meeting. From immune-training vaccines to approaches targeting DCIS and obesity-related risk, she shared how CVI is advancing prevention.

Read here: www.uwcvi.org/post/dr-nora...

#CancerResearch #CancerVaccines
May 5, 2026 at 8:45 PM
imtadvances.bsky.social
Marking World Immunization Week 2026 with a call for papers for Cancer Vaccines: Global Advances, highlighting cutting‑edge research in personalised and off‑the‑shelf cancer vaccines.

Submissions open until April 2026. 🧬

#WorldImmunizationWeek #CancerVaccines #CallForPapers
May 1, 2026 at 4:20 PM
currentmedscience.bsky.social
This review explores delivery strategies for #mRNA #CancerVaccines, addressing technical challenges and #BiologicalMechanisms, while highlighting breakthroughs that accelerate #ImmuneBased treatments. #medsky
To read: doi.org/10.1007/s115...
Development of mRNA Cancer Vaccines: Delivery Strategies and Immunogenicity Optimization
April 29, 2026 at 7:01 AM
xiahepublishing.bsky.social
🎯 Personalized vaccines are pushing precision medicine into a new phase, with oncology leading the charge. @ascocancer.bsky.social
#CancerVaccines
🔗 www.xiahepublishing.com/2835-3315/CS...
Personalized Vaccines: Unlocking the Next Era of Medical Innovation in Cancer Immunotherapy
Precision medicine represents a paradigm shift in healthcare, emphasizing individualized approaches to disease prevention, diagnosis, and treatment based on a patient’s genetic, proteomic, and immunologic profile. In the field of oncology, this paradigm has gained traction, particularly with the integration of immunotherapeutic modalities. Among the most promising advancements are therapeutic cancer vaccines, which harness the body’s immune system to fight tumors more effectively. This mini-review highlights recent developments in therapeutic vaccine engineering. It also discusses key barriers to clinical translation and summarizes findings from contemporary human clinical trials evaluating personalized cancer vaccines. In addition, it evaluates the growing potential of these therapies to redefine cancer treatment.
www.xiahepublishing.com
April 28, 2026 at 1:00 PM
minibubbly.bsky.social
After a year of turmoil, cancer researchers see promising signs for mRNA vaccines #CancerVaccines

www.ctvnews.ca/health/artic...
After a year of turmoil, cancer researchers see promising signs for mRNA vaccines
Vita Sara Blechner’s life changed on a Saturday afternoon. The middle school librarian was home in Oceanside, New York, when she felt shooting pains in her back. After an acid reflux pill couldn’t soo...
www.ctvnews.ca
April 20, 2026 at 2:53 PM
bionewscentral.com
#mRNAVaccines can trigger strong #AntiTumor #ImmuneResponses through an unexpected #ImmuneCell mechanism.
#CancerVaccines
mRNA vaccines follow unconventional immune path to destroy tumors – BioNews Central
mRNA vaccines can trigger strong anti-tumor immune responses through an unexpected immune cell mechanism. ...
sbee.link
April 17, 2026 at 4:11 PM
divyasawant02.bsky.social
How mRNA and Neoantigen Technologies Are Transforming the Cancer Vaccines Market

Source: www.panchit.com/blogs/5068/H...

#CancerVaccines #OncologyResearch #Immunotherapy #CancerTreatment
How mRNA and Neoantigen Technologies Are Transforming the Cancer...
Cancer immunotherapy has significantly transformed the treatment landscape by introducing innovative approaches that leverage the body’s immune system to fight malignant cells. Among these, cancer vac...
www.panchit.com
April 7, 2026 at 1:03 PM
xiahepublishing.bsky.social
🎯 Personalized vaccines are pushing precision medicine into a new phase, with oncology leading the charge. @ascocancer.bsky.social
#CancerVaccines
🔗 www.xiahepublishing.com/2835-3315/CS...
April 7, 2026 at 1:00 PM
fazencapital.bsky.social
Transgene Licenses NEC AI Platform for Cancer Vaccines: Transgene licensed NEC's AI platform on Apr 3, 2026 (Investing.com); NEC (founded 1899) supplies enterprise AI to accelerate Transgene's cancer vaccine… 👈 Read full analysis #CancerVaccines #AITechnology #Transgene #NEC #HealthcareInnovation
Transgene Licenses NEC AI Platform for Cancer Vaccines
Transgene licensed NEC's AI platform on Apr 3, 2026 (Investing.com); NEC (founded 1899) supplies enterprise AI to accelerate Transgene's cancer vaccine discovery.
dlvr.it
April 3, 2026 at 8:23 AM
magarianblander.bsky.social
Postdoc Opportunity in Neoepitope-based Cancer Immune Interception! Join our @ncicapit.org research at @weillcornell.bsky.social to link immunoprevention targets with preclinical cancer preventive interventions. Apply by emailing blanderadmin@med.cornell.edu. #Postdoc #immunology #cancervaccines
Postdoctoral Associate Position-Project Description
April 2, 2026 at 8:37 PM
natmed.nature.com
New Review on #CancerVaccines: John Haanen and colleagues highlight insights from recent clinical trials and discuss critical factors for optimization, with a focus on proxies for efficacy, #neoantigen selection, modular platforms and early intervention
www.nature.com/articles/s41...
Clinical development of cancer vaccines - Nature Medicine
This Review highlights insights from recent clinical trials and discusses critical factors for optimizing cancer vaccines, with a focus on proxies for vaccine efficacy, neoantigen selection, modular p...
www.nature.com
March 27, 2026 at 3:09 PM